Tuesday, September 26, 2023 6:55:13 PM
Recent MORF News
- Morphic to Participate in RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/09/2024 08:05:00 PM
- Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024 • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Morphic Appoints Dr. Simon Cooper as Chief Medical Officer • GlobeNewswire Inc. • 03/19/2024 12:00:00 PM
- Morphic to Participate in March Investor Conferences • GlobeNewswire Inc. • 03/05/2024 09:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/22/2024 12:46:53 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/22/2024 12:07:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:04:41 PM
- Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023 • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 12:04:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 12:03:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 12:02:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 12:00:45 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:08:03 PM
- Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 01:57:40 PM
- Morphic to Present at November Investor Conferences • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/03/2023 11:15:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 11:13:11 AM
- Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023 • GlobeNewswire Inc. • 11/03/2023 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 12:52:33 PM
- Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set • GlobeNewswire Inc. • 10/09/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 09:30:22 PM
- Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence • GlobeNewswire Inc. • 09/26/2023 08:10:00 PM
- Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023 • GlobeNewswire Inc. • 09/22/2023 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 11:00:27 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM